Latest Commercial Processing News

Ark Mines has produced high-grade monazite and titanium dioxide products from its Sandy Mitchell heavy mineral concentrate, marking a key step toward commercialising its North Queensland rare earths project.

Lodestar Minerals (ASX:LSR) confirms large-scale IOCG mineralisation in Chile and high-grade heavy rare earths in the USA, while progressing a 10,000m gold drilling program in Western Australia targeting a maiden resource.

Lodestar Minerals has verified xenotime as the dominant heavy rare earth mineral at its Virgin Mountain project in Arizona, highlighting critical elements essential for US defence and clean energy. The discovery positions the project as a strategic domestic source of scarce heavy rare earths.

Aumake Limited has secured a four-year exclusive global distribution agreement with EZZ Life Sciences, targeting $10 million in sales and expanding its footprint in high-margin nutraceuticals.

Meteoric Resources has cleared a major regulatory hurdle with the approval of its Preliminary Environmental License for the Caldeira Rare Earths Project, enabling the company to progress towards construction and first production targeted for 2028. The company also commissioned its pilot plant, producing its first batches of rare earth carbonate.

Resolution Minerals reports outstanding high-grade antimony, silver, and gold assay results from rock samples at its Antimony Ridge Mine in Idaho, reinforcing the project's strategic importance in the US critical minerals landscape.

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

BPM Minerals reports outstanding high-grade rare earth element assays from its Durack Project in Western Australia, highlighting the potential for a major monazite-hosted REE deposit. The discovery aligns with growing global demand and Australian government support for critical minerals.

ABx Group has achieved over 98% retention of rare earth elements with near-complete impurity removal in large batch tests from its Deep Leads project, advancing toward delivering its first mixed rare earth carbonate sample by November’s end.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Lunnon Metals has completed a detailed Scoping Study for its Lady Herial gold project, highlighting a high-grade open pit opportunity underpinned by predominantly measured resources. The company is advancing commercial negotiations and regulatory approvals, setting the stage for potential near-term development.

Lunnon Metals has completed a detailed Scoping Study for its Lady Herial gold deposit, confirming a short-life, high-grade open pit opportunity with strong financial prospects. The study, based largely on Measured and Indicated Resources, sets the stage for commercial negotiations with Gold Fields and potential near-term production.